| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 02/15/2011 | US7888092 Nucleic acid molecules encoding transmembrane serine proteases, the encoded proteins and methods based thereon |
| 02/15/2011 | US7888089 Nucleotide sequences coding polypeptide for use in the treatment of cardivascular, restenosis, hypertension, atherosclerosis, heart defects, diabetes and neovascularization disorders; endothelial nitric oxide synthase (eNOS) |
| 02/15/2011 | US7888071 DNA encoding IL-2 fusion proteins with modulated selectivity |
| 02/15/2011 | US7888066 Diagnosing nervous system disorders; obtain tissue sample, measure expression of semaphorin 3 and downstream effectors , amplified concentrations of semaphorins indicate nervous system disorders; drug screening |
| 02/15/2011 | US7888057 Immunological assay for plasmin-digested products of stabilized fibrin |
| 02/15/2011 | US7888055 Selectively binds with absolute control over orientation and density without requiring prior synthetic modification or purification to make a stable protein chip; rapid and irreversible; assaying kinase or protease activity |
| 02/15/2011 | US7888054 for determining whether an animal is naturally-infected with Ehrlichia canis, or is either not infected or is vaccinated with an E. canis vaccine |
| 02/15/2011 | US7888053 Making encoded ghost cells for multiplexed detection of anti-red cell alloantibodies |
| 02/15/2011 | US7888052 detecting a Cripto polypeptide; for in vitro diagnostics/antitumor agents; gene overexpression of cell surface proteins; bind Cripto and block the interaction between Cripto and activin-like kinase (ALK) 4 |
| 02/15/2011 | US7888051 Method of identifying biomarkers in human serum indicative of pathologies of human lung tissues |
| 02/15/2011 | US7888050 Method for quantifying phosphokinase activity on proteins |
| 02/15/2011 | US7888049 Rapid nasal assay kit |
| 02/15/2011 | US7888048 P4HAS as modifiers of the IGFR pathway and methods of use |
| 02/15/2011 | US7888047 PDEs as modifiers of the IGFR pathways and methods of use |
| 02/15/2011 | US7888046 Voltage sensor domains of voltage-dependent ion channel proteins and uses thereof |
| 02/15/2011 | US7888045 Methods for identifying modulators of SF taste receptor signaling |
| 02/15/2011 | US7888044 Melanoma biomarker and methods of uses |
| 02/15/2011 | US7888043 detection of anti-lipoidal antibodies and the diagnosis of disease such as syphilis; by use of oxidized cardiolipins that is immunoreactive with anti-lipoidal antibodies; preparation of the oxidized cardiolipin |
| 02/15/2011 | US7888042 Methods for identifying insulin mimetics |
| 02/15/2011 | US7888041 In vitro diagnostic method and kit for an Aspergillus infection |
| 02/15/2011 | US7888040 highly specific; methamphetamine, ecstacy, (+/-)-N-methyl-1-(3,4-methylenedioxyphenyl)-2-butanamine (MBDB) and (+/-)-3,4-methylenedioxyethylamphetamine (MDEA); for use in the laboratory, point-of-care and on-site testing; without significant interference from other phenyethylamine derivatives |
| 02/15/2011 | US7888039 uses the heat shock protein 60 (Hsp60) of Spiroplasma mirum; rapid detection, noninvasive ; Spiroplasma infection |
| 02/15/2011 | US7888038 modulating apoptosis-induced cell death comprising modulating the level of Bak Binding Protein (BBP) in a eukaryotic cell; drug screening |
| 02/15/2011 | US7888037 Diagnostic kit for detecting pulmonary and extra pulmonary tuberculosis |
| 02/15/2011 | US7888011 Methods for isolation of nucleic acids from prokaryotic spores |
| 02/15/2011 | US7888007 Cancer associated plexin B1 mutations |
| 02/15/2011 | US7888002 silver amplification method for realizing a high sensitivity of an immunochromatography using a gold colloid as a labeling substance; does not require the time and effort for mixing liquids immediately before silver amplification |
| 02/15/2011 | US7888000 Apparatus which utilizes 25-hydroxyvitamin D3 binding activity to diagnose and predict hypertension |
| 02/15/2011 | US7887815 Peptide diagnostic agent for lyme disease |
| 02/15/2011 | US7887808 Human Rgr oncogene and truncated transcripts thereof detected in T cell malignancies, antibodies to the encoded polypeptides and methods of use |
| 02/15/2011 | US7887806 Mammalian receptor proteins DCRS5; method of treatment |
| 02/15/2011 | US7887804 Methods for treating disease-states associated with RG1 using immunoconjugates |
| 02/15/2011 | US7887800 activating endothelial growth factors VEGF-C or vascular endothelial growth factor D (VEGF-D) with plasmin; Angiogenesis |
| 02/15/2011 | US7887799 Antibodies to fibroblast growth factor-like polypeptides |
| 02/15/2011 | US7887754 Polymeric solid supports for chromatography nanocolumns |
| 02/15/2011 | US7887753 Apparatus and methods for conducting assays and high throughput screening |
| 02/15/2011 | US7887750 Analytical systems, devices, and cartridges therefor |
| 02/15/2011 | US7887690 for separating, by electrophoresis, a first sample DNA including a first base sequence, and a second sample DNA including a second base sequence that is partially different from first base sequence, which are contained in sample solution; for detecting differences in portions of base sequences of DNAs |
| 02/15/2011 | US7887686 analyzing a biological blood sample for separating and resolving hemoglobins; using a zwitterionic type buffer solution including one flow inhibitor amines |
| 02/15/2011 | US7886590 Apparatus and method for quantitatively measuring liquid film drying rates on substrates |
| 02/15/2011 | CA2604099C Proteolipid membrane & lipid membrane biosensor |
| 02/15/2011 | CA2529452C Serum cholesterol lowering agent or preventive or therapeutic agent for atherosclerosis |
| 02/15/2011 | CA2519993C Ph-dependent polypeptide aggregation and its use |
| 02/15/2011 | CA2465297C Method of mass spectrometry |
| 02/15/2011 | CA2452445C Modulators of cellular proliferation and angiogenesis, methods for use and identification thereof |
| 02/15/2011 | CA2449040C Directed assembly of functional heterostructures |
| 02/15/2011 | CA2433535C Materials and methods relating to protein aggregation in neurodegenerative disease |
| 02/15/2011 | CA2433071C Use of transcription factor yb-1 in adenoviral systems |
| 02/15/2011 | CA2429473C Membrane scaffold proteins |
| 02/15/2011 | CA2416757C Prodrugs of phosphonate nucleotide analogues and methods for selecting and making same |
| 02/15/2011 | CA2414316C Analysis method using a non-hygroscopic hemolysing agent and cuvette therefore |
| 02/15/2011 | CA2407046C Immunoregulator |
| 02/15/2011 | CA2396342C Sandwich immunoassay and monoclonal antibodies for comp, cartillage oligomeric matrix protein |
| 02/15/2011 | CA2383424C Novel b7-4 molecules and uses therefor |
| 02/15/2011 | CA2380272C Stable near-infrared (nir) marker dyes based on benzopyrylium-polymethines |
| 02/15/2011 | CA2352765C Hapten-carrier conjugates for treating and preventing nicotine addiction |
| 02/15/2011 | CA2311679C Use of a soluble recombinant human cd40l protein for inhibiting in vivo immune response |
| 02/15/2011 | CA2301826C Chimeric binding peptide library screening method |
| 02/15/2011 | CA2295332C Aib1, a novel steroid receptor co-activator |
| 02/15/2011 | CA2192235C Flt4 receptor tyrosine kinase and its use in diagnosis and therapy |
| 02/15/2011 | CA2074370C Synthetic antigens for the detection of antibodies to hepatitis c virus |
| 02/14/2011 | CA2675539A1 Recycling of grey water |
| 02/11/2011 | CA2807557A1 Diagnosis of primary and metastatic basal-like breast cancer and other cancer types |
| 02/10/2011 | WO2011017707A1 Determination of nitrate/nitrite concentration in water by photochemical reduction |
| 02/10/2011 | WO2011017696A2 Methods relating to aromatase inhibitor pharmacogenetics |
| 02/10/2011 | WO2011017691A2 Enhanced molecular detection of targeted intracellular mrna transcription using polynucleotide functionalized nanoparticles |
| 02/10/2011 | WO2011017685A1 Methods and devices for detecting kidney transplant rejection |
| 02/10/2011 | WO2011017684A1 Methods and devices for detecting diabetic nephropathy and associated disorders |
| 02/10/2011 | WO2011017683A1 Methods and devices for detecting kidney damage |
| 02/10/2011 | WO2011017682A1 Devices for detecting renal disorders |
| 02/10/2011 | WO2011017681A2 Device and method for molecular analysis |
| 02/10/2011 | WO2011017679A1 Methods and devices for detecting glomerulonephritis and associated disorders |
| 02/10/2011 | WO2011017678A1 Methods and devices for detecting obstructive uropathy and associated disorders |
| 02/10/2011 | WO2011017677A2 Device and methods for epigenetic analysis |
| 02/10/2011 | WO2011017660A2 Magnetic carbon nanotube based biodetection |
| 02/10/2011 | WO2011017654A1 Methods and compositions for diagnosis and prognosis of renal injury and renal failure |
| 02/10/2011 | WO2011017614A1 Methods and compositions for diagnosis and prognosis of renal injury and renal failure |
| 02/10/2011 | WO2011017605A2 Device and methods for the immunological identification of cerebrospinal fluid |
| 02/10/2011 | WO2011017567A1 Methods for the analysis of proximity binding assay data |
| 02/10/2011 | WO2011017564A2 Identification and use of compounds for treating persistent pain |
| 02/10/2011 | WO2011017537A2 High throughput screen for measuring membrane effects |
| 02/10/2011 | WO2011017436A2 A high precision quantitative assay composition and methods of use therefor |
| 02/10/2011 | WO2011017369A1 A lectin assay for assessing glycoforms as an early marker in disease |
| 02/10/2011 | WO2011017325A1 Sampling devices and methods of use |
| 02/10/2011 | WO2011017317A1 Method of detecting oxides of nitrogen |
| 02/10/2011 | WO2011017293A2 Engineering of zinc finger arrays by context-dependent assembly |
| 02/10/2011 | WO2011017257A1 Method of detection and related detection device |
| 02/10/2011 | WO2011017229A2 Plasma complement components as expression markers for age-related macular degeneration and related phenotypes |
| 02/10/2011 | WO2011017164A1 Methods for detection of influenza virus and compositions therefor |
| 02/10/2011 | WO2011017151A2 Pairing processes for preparing alloreactive cytotoxic t cells |
| 02/10/2011 | WO2011017145A2 Biomarkers for gossypol chemotherapy and methods of treating disease |
| 02/10/2011 | WO2011017126A1 Biomarker of lung cancer |
| 02/10/2011 | WO2011017120A1 Use of ccr9, ccl25, batf and il17/il23 pathway variants to diagnose and treat inflammatory bowel disease |
| 02/10/2011 | WO2011017106A1 Skp2 as a biomarker for rapamycin resistance |
| 02/10/2011 | WO2011017094A2 Assay apparatuses, consumables and methods |
| 02/10/2011 | WO2011017077A2 Nanochannel-based sensor system with controlled sensitivity |
| 02/10/2011 | WO2011017013A2 Enterococcus and fecal bacteroides for rapid water quality assessment |
| 02/10/2011 | WO2011016904A1 Mobile sampling of target substances |
| 02/10/2011 | WO2011016890A1 System, device, and methods for real-time screening of live cells, biomarkers, and chemical signatures |
| 02/10/2011 | WO2011016869A1 Methods and compositions for drug discovery |